|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.06 USD | -5.75% |
|
-4.46% | -8.18% |
EPS & Dividend: Summit Therapeutics Inc.
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | -0.7828 | -0.2452 | -0.9653 | -0.7285 | -0.684 |
| Distribution rate | - | - | - | - | - |
| Reference price 2 | 2.05 | 14.25 | 11.93 | 11.93 | 11.93 |
| Nbr of stocks (in thousands) | 700,843 | 737,448 | 771,150 | 771,150 | - |
| Announcement Date | 20/02/24 | 24/02/25 | - | - | - |
1GBP in Million2GBP
Estimates
Upcoming events: Summit Therapeutics Inc.
| 11/03/2026 | Q4 2025 Earnings Release (Projected) |
| 06/05/2026 | Q1 2026 Earnings Release (Projected) |
| 11/08/2026 | Q2 2026 Earnings Release (Projected) |
| 10/11/2026 | Q3 2026 Earnings Release (Projected) |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | -12.36x | - | 154.27x | |
| 0.02% | 0.04% | 45.34x | 7.21x | 10.86x | |
| 1.69% | 1.54% | 17.23x | 4.13x | 6.14x | |
| -.--% | -.--% | -27.64x | 93.03x | 60.6x | |
| -.--% | -.--% | -26.54x | 1.21x | 4.45x | |
| -.--% | -.--% | 30.66x | 2.84x | 6.04x | |
| -.--% | -.--% | 16.91x | 3.25x | 4.25x | |
| -.--% | -.--% | -407.81x | 12.74x | 27.93x | |
| -.--% | -.--% | -192.39x | 23.58x | 45.66x | |
| - | - | - | - | - | |
| Average | 0.19% | 0.18% | -61.84x | 18.50x | 35.58x | |
| Weighted average by Cap. | 0.31% | 0.29% | -26.49x | 20.14x | 26.47x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition